GlassScriptPhysician profile
Kenneth Cohn
NPI 1578581187
$4,073.92
in general payments reported to CMS, 2019-2025
19 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $671 · 2021: $310 · 2022: $856 · 2023: $590 · 2024: $779 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Entertainment: $22.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.13 |
| Entertainment | $22.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $840.74 | 2022-2025 | Tyrvaya |
| Allergan, INC. | $739.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $552.87 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $315.15 | 2022-2025 | Miebo, Xiidra, Lotemax Sm |
| Abbvie INC. | $312.18 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $251.14 | 2019-2025 | Cequa |
| Alcon Vision LLC | $183.45 | 2022-2025 | Rocklatan, Eysuvis |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $173.26 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $161.02 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $107.80 | 2020-2022 | |
| Harrow Eye, LLC | $102.47 | 2024-2025 | Vevye |
| Horizon Therapeutics Plc | $74.82 | 2021-2023 | Tepezza |
| Shire North American Group INC | $68.23 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $54.40 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $42.36 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $32.17 | 2022 | |
| Thea Pharma INC. | $22.80 | 2023 | |
| Optos, INC. | $22.74 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $16.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.